Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support

      In December 2019, an outbreak of a severe respiratory viral illness was first identified in the Hubei province of China. The illness was later discovered to be caused by infection with a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
      To read this article in full you will need to make a payment


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zochios V.
        • Parhar K.
        • Vieillard-baron A.
        Protecting the right ventricle in ARDS: the role of prone ventilation.
        J Cardiothorac Vasc Anesth. 2018; 32: 2248-2251
        • Zhou F.
        • Yu T.
        • Du R.
        • Fan G.
        • Liu Y.
        • Liu Z.
        • et al.
        Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
        Lancet. 2020; 395: 1054-1062
        • Ankersmit H.J.
        • Tugulea S.
        • Spanier T.
        • Weinberg A.D.
        • Artrip J.H.
        • Burke E.M.
        • et al.
        Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device.
        Lancet. 1999; 354: 550-555
        • Kimball P.M.
        • Flattery M.
        • Mcdougan F.
        • Kasirajan V.
        Cellular immunity impaired among patients on left ventricular assist device for 6 months.
        Ann Thorac Surg. 2008; 85: 1656-1661